Skip to content

CAPSTONE® Spinal System 2991222Recalls & reported problems

Medtronic Sofamor Danek, Inc. · SPACER 2991222 CAPSTONE PEEK 12X22 · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00613994290960), received between Oct 5, 2017 and Oct 21, 2024 — classified as 4 injuries.

The most frequently reported specific device problem is “Migration or Expulsion of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Migration or Expulsion of Device1

Patient problems

  • Apnea1
  • Encephalopathy1
  • Fever1
  • Neuropathy1
  • No Known Impact Or Consequence To Patient1
  • Pain1
  • Post Operative Wound Infection1
  • Unspecified Infection1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 21, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    INFORMATION WAS RECEIVED FROM MULTIPLE SOURCES (MANUFACTURER REPRESENTATIVE, HEALTHCARE PROVIDER, CLINICAL STUDY) REGARDING AN EVENT WHICH OCCURRED POST A CLINICAL STUDY (STUDY ID: (B)(4)) SPINAL FUSION PROCEDURE IN A PATIENT (PATIENT ID: (B)(6)). IT WAS REPORTED THAT PATIENT REPORTS LOW BACK PAIN AND RATES IT A 6-7 OUT OF 10. MILD PAIN WITH RANGE OF MOTION. PI STATES PROBABILITY OF MILD DISC STRAIN AND COMPLETED A STEROID INJECTION. REFILLED DICLOFENAC AND FLEXERIL FOR PAIN CONTROL. PRESCRIBED PHYSICAL THERAPY AND IF NO IMPROVEMENTS IN 6-8 WEEKS, THEN WILL SEND FOR AN MRI. PATIENT ALSO HAD ACUTE CYSTITIS, HYPOXIC-ISCHEMIC ENCEPHALOPATHY, LUMBAR RADICULOPATHY, SEVERE OBSTRUCTIVE SLEEP APNEA. NO PRODUCT MALFUNCTION REPORTED. SPONSOR ASSESSMENT: NOT RELATED TO PROCEDURE, POSSIBLE TO TLIF GRAFTING MATERIAL (AUTOGRAFT), BODY FUSION DEVICE (CAPSTONE), AND POSTERIOR SUPPLEMENTAL FIXATION SYSTEM. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT.ENT.

    Patient problems: Apnea; Encephalopathy; Neuropathy; Pain

    MAUDE report 20492254 ↗
  • InjuryFeb 7, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    INFORMATION WAS RECEIVED FROM A REGULATORY BODY VIA MANUFACTURER REPRESENTATIVE REGARDING A PATIENT WITH AN UNKNOWN INDICATION FOR SPINAL THERAPY. IT WAS REPORTED THAT POSTERIOR LUMBAR DECOMPRESSION, BONE GRAFTING, FUSION AND INTERNAL FIXATION WERE PERFORMED ON (B)(6) 2023. LUMBAR 4, LUMBAR 5, AND SACRAL 1 PEDICLES WERE IMPLANTED, WITH A TOTAL OF 6 CROSSLINKS. A FUSION CAGE WAS IMPLANTED BETWEEN THE FOURTH AND FIFTH LUMBAR VERTEBRAE. WOUND INFECTION WAS FOUND ON (B)(6) 2023, AND A POSTERIOR LUMBAR DEBRIDEMENT, SUTURE, PERFUSION, IRRIGATION AND DRAINAGE WAS PERFORMED. THE PATIENT HAD A HYPERSENSITIVE CONSTITUTION, WAS ALLERGIC TO CEPHALOSPORIN ANTIBIOTICS, AND THE ANTIBIOTICS USED TO PREVENT INFECTION WERE NOT STRONG ENOUGH.

    Patient problems: Post Operative Wound Infection

    MAUDE report 18656825 ↗
  • InjuryMar 16, 2018Migration or Expulsion of Device; Migration or Expulsion of Device

    INITIAL PROCEDURE: POSTERIOR LUMBAR INTERBODY FUSION PRE-OP DIAGNOSIS: CAGE BETWEEN THE L2/3 BACKED-OUT AND L2 SCREW LOOSENED IT WAS REPORTED THAT ON AN UNKNOWN DATE, POST-OP, THE CAGE BETWEEN L2/3 BACKED OUT AND THE S4 SCREW ON L2 LOOSENED. NO BREAKAGE OF PRODUCTS WAS REPORTED. AN ADDITIONAL SURGERY WAS PLANNED TO BE PERFORMED ON (B)(6). NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THE EVENT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7344223 ↗
  • InjuryOct 5, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT PATIENT UNDERWENT POSTERIOR LUMBAR FUSION DUE TO DISC HERNIATION. POST-OP, INTER-VERTEBRAL SPACE INFECTION WAS OBSERVED ACCOMPANIED BY FEVER DISCOMFORT. PATIENT WAS HOSPITALIZED. PRODUCTS REMAIN IN THE PATIENT'S BODY. POST-OPERATIVE DEBRIDEMENT SURGERY WAS PERFORMED.

    Patient problems: Fever; Unspecified Infection

    MAUDE report 6916562 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page